Krista Payne, Executive Director & Principal Scientific Consultant, Value Demonstration, does what few people can – she brings together robust scientific methods, strategic and innovative approaches, and a collaborative spirit. Her achievements have not gone unnoticed.
Unlike controlled studies, observational studies have the potential to collect data on thousands – even millions – of patients. Increasingly, manufacturers are asked for information and data that only these kinds of studies can provide.
Observational studies can be used to help manufacturers and their stakeholders understand the clinical, patient-centered, and economic burden of disease, as well as the value of different treatments in reducing that burden.
Last week, more than 100 senior Late Phase pharmaceutical professionals and key opinion leaders representing Medical and Scientific Affairs, Health Economics and Outcomes Research, Safety and Risk Management, Regulatory, Market Access and Drug Reimbursement met in Berlin, Germany, at the Third Annual Medical Affairs Leaders Forum.
A study, designed and undertaken by medical and industry experts including Krista Payne and Noreen Lordan of UBC, assesses the health-related quality of life (HRQoL) of 154 patients with multiple myeloma (MM). This cross-sectional, bi-national, multicenter study enrolled patients with MM presenting for routine care visits at five United Kingdom and six German sites.
The convergence of payer and regulator evidence requirements warrants a strategic evidence generation plan and a mindful orchestration of peri and postapproval real-world studies. Study designs resulting in a diverse array of health economic and safety data are increasingly warranted to meet the demands of various stakeholders.
UBC experts Krista Payne MEd, Executive Director of Value Demonstration; Safety, Epidemiology, Registries and Risk Management and Principal Scientific Consultant, and Dara Stein, MSc, Senior Research Associate, Value Demonstration, Safety, Epidemiology, Registries and Risk Management, have written a comprehensive overview on retrospective chart studies online now at PharmaPhorum.com.
UBC scientists never stop learning. And, they never stop sharing what they’ve learned. As healthcare professionals committed to improving patient outcomes, our scientists often use their research and studies for teaching opportunities.
Congratulations to three of our clinical experts whose abstracts were selected for the upcoming ICPE conference.